Cover Image

2012 GCP Question & Answer Guide 


Good Clinical Practices Question and Answer Guide 2012 (Hard Copy)

The GCP Question & Answer (Q&A) Guide - For CRAs, investigators/sites, auditors, compliance, legal, and other clinical professionals


What's new for 2012? 

  • Addition of an Expert Advisory Panel including distinguished international GCP experts who have assured that the book contains the most current and up-to-date information on global GCP requirements
  • Numerous new Q&As, including questions addressing emerging topics such as the new risk-based approach to monitoring clinical trials, and new changes and information to be provided in informed consent documents
  • Completely updated sections featuring all the latest data and trends on the FDA and EMA's clinical trial compliance inspections, inspectional findings, and common areas of GCP noncompliance 
  • 200+ Q&As updated to reflect the very latest FDA guidances, regulations, comments, and developments
  • Revised and updated sections on GCP compliance and clinical trial requirements in numerous regions of the world outside the US, such as Canada, Latin America, India, and Eastern Europe

About Barnett’s GCP Q&A Guide: 

At its core, Good Clinical Practice (GCP) is a set of broad regulatory requirements, standards, and recommendations that apply to thousands of highly specific tasks, processes, and roles in the conduct of clinical research. It is important to remember that much of the practical standards used in the conduct of clinical trials are "best practices" derived from regulations, guidances, and industry standards and practices and not all found in black and white in the regulations. Given the disparity between the detailed nature of clinical trial processes and tasks and the general GCP requirements and standards under which they occur, it is not surprising that interpreting and implementing GCP standards continue to represent challenges for the pharmaceutical, biotechnology, and medical device industries. 

In Barnett’s comprehensive guide, you'll have authoritative answers to hundreds of common and emerging questions in 20+ GCP-related areas, right at your fingertips:

  • FDA and ICH GCP Standards for Clinical Research
  • Form FDA 1572-Statement of Investigator
  • Informed Consent
  • Patient Recruitment
  • State Standards and GCP
  • Source Data/Documentation
  • Investigator/Site Requirements
  • Clinical Monitoring
  • Clinical Study Safety Reporting
  • Clinical Trial Protocols/Protocol Changes/Protocol Violations
  • Institutional Review Boards
  • Quality Assurance Activities/Study Auditing/FDA Inspections, Investigational Drug Accountability, Administration, and Labeling

Barnett’s guide also provides all FDA, ICH, and EU GCP-related regulations and guidances in one source!

Reader Testimonials: 

"This book should be mandatory reading for every person involved in clinical research."Munish Mehra, Ph.D., Managing Director, Global Drug Development Experts 

"Unless you already know everything there is to know about GCP, we recommend that you buy this book. This book is excellent."Graeme Scott, Anjo Strik, and Jean Saint-Pierre in The Quality Assurance Journal 

"The book is the most important advance in clinical research education in quite some time... A valuable tool that I recommend every clinical research professional have on their desk."Lisa Zimmerman, MS, Director of QA and Regulatory Compliance, Duke Clinical Research Institute 

"This book is already a leader among GCP references and one that offers an immediate return for readers."William Hirschhorn, Drexel University College of Medicine 

Editorial Team: 

Editor in Chief:  Michael Hamrell, PhD, RAC, RQAP-GCP, President, MORIAH Consultants
Editor Emeritus: Mark Mathieu, PAREXEL International Corporation

2012 Expert Advisory Panel: 

  • Anne Blanchard, Blanchard & Associates (Argentina)
  • Glenda Guest, NCRA (USA)
  • Stuart Horowitz, Huron Consulting Group (USA)
  • Linda Houle, Linda Houle and Associates (Canada)
  • Earl Hulihan, Medidata Solutions (USA)
  • John Isidor, Schulman Associates IRB (USA)
  • M. Joseph Mardesich, Quality Compliance Consulting, Inc. (USA)
  • Munish Mehra, Quantum Biopharma (USA)
  • Jules Mitchel, Target Health Inc. (USA)
  • Raeda Mustafa, Molecule CRO (Jordan)
  • James Nickas, BioMarin Pharmaceuticals (USA)
  • Deidra Poucher, Norton Audits, (USA)
  • Alicia Pouncey, Aureus Consulting (USA)
  • Ernest Prentice, MD, University of Nebraska (USA)
  • Sandra “SAM” Sather, Clinical Pathways Research (USA)
  • Adil Shamoo, MD., University of Maryland (USA)
  • Teri Stokes, GXP International (USA)
  • Michael A. Swit, Duane Morris LLP (USA)
  • Beat Wilder, E. PhD, (Switzerland)

Approx. 750 pp.
Call 1-800-856-2556 for Multiple Copy Discounts & Custom Covers!